Explore the drug carrier protein. Please reference it

Drug Carrier Proteins

Drug carrier proteins are a class of proteins that bind to drug molecules and facilitate their transport across biological membranes or within the body. They play a crucial role in pharmacokinetics, influencing drug absorption, distribution, metabolism, and excretion (ADME). These proteins can be broadly categorized into two main types:

1. Plasma Proteins: These proteins are found in the blood plasma and bind reversibly to drugs. The most abundant plasma protein that binds drugs is albumin, which primarily transports hydrophobic (water-repelling) drugs. Other plasma proteins like alpha-1-acid glycoprotein (AAG) and lipoproteins also bind to specific classes of drugs. Drug binding to plasma proteins is generally non-specific and reversible. Only the unbound or free fraction of a drug is pharmacologically active and available to distribute into tissues, exert its effect, or be eliminated. High binding to plasma proteins can reduce the volume of distribution and the rate of elimination, potentially prolonging the drug's duration of action.

   • Example: Warfarin, a widely used anticoagulant, is highly bound (>97%) to albumin.

2. Membrane Transporter Proteins: These proteins are embedded within cell membranes and actively or passively move drugs and other molecules across these barriers. They are essential for drug uptake into cells, efflux (removal) from cells, and transport across specialized barriers like the blood-brain barrier or the intestinal epithelium. Key families of membrane transporters include:

   • ATP-binding cassette (ABC) transporters: These are active efflux pumps that use ATP hydrolysis to move drugs out of cells. The most well-studied is P-glycoprotein (P-gp), also known as multidrug resistance protein 1 (MDR1). P-gp is found in the intestines, liver, kidneys, and blood-brain barrier, and it can pump a wide range of drugs out of cells, contributing to drug resistance in cancer and limiting drug entry into the brain.
   • Solute carrier (SLC) transporters: This is a large and diverse family of transporters that mediate the uptake or efflux of various substrates, including drugs. Examples include:
     • Organic anion transporters (OATs) and organic cation transporters (OCTs), which are important for drug uptake into the liver and kidneys for excretion.
     • Peptide transporters (PEPTs), which can transport peptide-like drugs.
     • Hepatocyte OATP family, involved in drug uptake into hepatocytes.

Significance in Drug Therapy:

• Drug Interactions: Competition for binding sites on plasma proteins or shared transporter proteins can lead to drug interactions, altering the free concentration of one or both drugs.
• Therapeutic Efficacy and Toxicity: The extent of drug binding and transport influences the concentration of the drug at its site of action and in organs of elimination, thereby affecting both efficacy and toxicity.
• Drug Resistance: Overexpression of efflux transporters like P-gp is a major mechanism of multidrug resistance in cancer chemotherapy.
• Targeted Delivery: Understanding carrier proteins can aid in designing drug delivery systems that exploit specific transporters to deliver drugs to desired tissues.

References:

• Goodman & Gilman's: The Pharmacological Basis of Therapeutics (a standard pharmacology textbook).
• Katzung, B. G., Masters, S. B., & Trevor, A. J. (Eds.). (2018). Basic & Clinical Pharmacology (14th ed.). McGraw-Hill Education.
• Borst, P., & Schinkel, A. H. (2013). ABC transporters in medicine and disease. Nature Reviews Cancer, 13(9), 655-662. (This is a review article focusing on ABC transporters).
• Pascale, A., et al. (2017). Drug transporters: a review of their role in drug development. Drug Discovery Today, 22(1), 108-117. (This is a review article on drug transporters).